Genetic and environmental influences on the progression from alcohol use disorder to alcohol-related medical conditions.


Journal

Alcoholism, clinical and experimental research
ISSN: 1530-0277
Titre abrégé: Alcohol Clin Exp Res
Pays: England
ID NLM: 7707242

Informations de publication

Date de publication:
12 2021
Historique:
revised: 27 09 2021
received: 12 07 2021
accepted: 21 10 2021
pubmed: 20 12 2021
medline: 23 3 2022
entrez: 19 12 2021
Statut: ppublish

Résumé

Medical conditions related to alcohol use disorders (AUD) represent a substantial public health concern. However, only a subset of individuals with AUD develop these conditions and the extent to which genetic and environmental factors that are shared with AUD, versus those distinct from it, contribute to this progression has not yet been determined. Using data from Swedish national registries for a cohort born from 1932 to 1970 (N = 1,319,214, 48.9% women), we conducted twin-sibling biometric model fitting to examine the genetic and environmental sources of variance that contribute to the liability to alcohol-related medical conditions (AMC). Progression to AMC, determined using medical registry data, was contingent on an AUD registration, which was determined using medical and criminal registry data. We identified AUD registrations in 3.2% of women and 9.2% of men. Among individuals with an AUD registration, 14.4% of women and 15.4% of men had an AMC registration. In the final models, we constrained the beta pathway from AUD to AMC and the genetic and unique environmental paths to be equal across sexes. The beta path was estimated at 0.59. AMC was modestly heritable in women (A = 0.32) and men (A = 0.30). The proportion of total heritability unique to AMC was 39.6% among women and 41.3% among men. A higher proportion of total environmental variance was unique to AMC: 76.7% for women and 77.2% for men. In a sensitivity analysis limited to liver-related AMC, we observed similar results, with a slightly lower beta path from AUD to AMC (0.46) and higher proportions of AMC-specific genetic (70.0% in women; 71.7% in men) and environmental (84.5% in both sexes) variance. A moderate-to-substantial proportion of genetic and environmental variance that contributes to AMC risk is not shared with AUD, underscoring the need for additional gene identification efforts for AMC. Furthermore, the prominent influence of environmental factors specific to AMC provides a promising area for the identification of prevention targets. We did not observe significant sex differences in the etiology of AMC, although follow-up is warranted in other well-powered studies.

Sections du résumé

BACKGROUND
Medical conditions related to alcohol use disorders (AUD) represent a substantial public health concern. However, only a subset of individuals with AUD develop these conditions and the extent to which genetic and environmental factors that are shared with AUD, versus those distinct from it, contribute to this progression has not yet been determined.
METHODS
Using data from Swedish national registries for a cohort born from 1932 to 1970 (N = 1,319,214, 48.9% women), we conducted twin-sibling biometric model fitting to examine the genetic and environmental sources of variance that contribute to the liability to alcohol-related medical conditions (AMC). Progression to AMC, determined using medical registry data, was contingent on an AUD registration, which was determined using medical and criminal registry data.
RESULTS
We identified AUD registrations in 3.2% of women and 9.2% of men. Among individuals with an AUD registration, 14.4% of women and 15.4% of men had an AMC registration. In the final models, we constrained the beta pathway from AUD to AMC and the genetic and unique environmental paths to be equal across sexes. The beta path was estimated at 0.59. AMC was modestly heritable in women (A = 0.32) and men (A = 0.30). The proportion of total heritability unique to AMC was 39.6% among women and 41.3% among men. A higher proportion of total environmental variance was unique to AMC: 76.7% for women and 77.2% for men. In a sensitivity analysis limited to liver-related AMC, we observed similar results, with a slightly lower beta path from AUD to AMC (0.46) and higher proportions of AMC-specific genetic (70.0% in women; 71.7% in men) and environmental (84.5% in both sexes) variance.
CONCLUSIONS
A moderate-to-substantial proportion of genetic and environmental variance that contributes to AMC risk is not shared with AUD, underscoring the need for additional gene identification efforts for AMC. Furthermore, the prominent influence of environmental factors specific to AMC provides a promising area for the identification of prevention targets. We did not observe significant sex differences in the etiology of AMC, although follow-up is warranted in other well-powered studies.

Identifiants

pubmed: 34923650
doi: 10.1111/acer.14731
pmc: PMC8712390
mid: NIHMS1751853
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2528-2535

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA023534
Pays : United States

Informations de copyright

© 2021 by the Research Society on Alcoholism.

Références

Alcohol Clin Exp Res. 2011 Dec;35(12):2152-61
pubmed: 21689117
Alcohol Clin Exp Res. 2003 Nov;27(11):1798-804
pubmed: 14634496
World J Gastroenterol. 2010 Mar 21;16(11):1377-84
pubmed: 20238405
Twin Res Hum Genet. 2016 Oct;19(5):430-7
pubmed: 27515133
Arch Gen Psychiatry. 1981 Aug;38(8):861-8
pubmed: 7259422
Hepatology. 2021 May;73(5):1920-1931
pubmed: 32853455
Gut. 2015 Sep;64(9):1426-33
pubmed: 25253127
Hepatology. 2007 Dec;46(6):2032-9
pubmed: 18046720
Am J Psychiatry. 2019 Feb 1;176(2):107-118
pubmed: 30336701
Alcohol Clin Exp Res. 1981 Spring;5(2):207-15
pubmed: 7018299
Psychol Med. 1999 Mar;29(2):299-308
pubmed: 10218922
Alcohol Clin Exp Res. 1996 Dec;20(9):1528-33
pubmed: 8986199
Nat Commun. 2019 Apr 2;10(1):1499
pubmed: 30940813
Ann Hepatol. 2017 Aug 1;16(4):490-500
pubmed: 28612750
Gastroenterology. 2021 Apr;160(5):1620-1633.e13
pubmed: 33310085
Psychometrika. 2016 Jun;81(2):535-49
pubmed: 25622929
World J Gastroenterol. 2013 Feb 7;19(5):638-47
pubmed: 23429423
N Engl J Med. 1990 Jan 11;322(2):95-9
pubmed: 2248624
Front Biosci (Schol Ed). 2018 Jan 1;10:65-100
pubmed: 28930519
Psychol Med. 2015 Apr;45(5):1061-72
pubmed: 25171596
Clin Gastroenterol Hepatol. 2020 Dec 4;:
pubmed: 33279778
Adv Alcohol Subst Abuse. 1988;7(3-4):3-16
pubmed: 3066194
Alcohol Res Health. 2003;27(3):209-19
pubmed: 15535449
Hepatology. 1996 May;23(5):1025-9
pubmed: 8621128
Nat Genet. 2021 Jan;53(1):35-44
pubmed: 33414549
Arch Gen Psychiatry. 1993 Jan;50(1):36-43
pubmed: 8422220
Am J Gastroenterol. 1998 Nov;93(11):2022-36
pubmed: 9820369
Gastroenterology. 2020 Oct;159(4):1276-1289.e7
pubmed: 32561361
Alcohol Clin Exp Res. 2021 Apr;45(4):709-719
pubmed: 33616244
Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):219-31
pubmed: 20510824
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1140-3
pubmed: 6786474
Nat Hum Behav. 2019 May;3(5):513-525
pubmed: 30962613
Am J Prev Med. 2015 Nov;49(5):e73-e79
pubmed: 26477807

Auteurs

Alexis C Edwards (AC)

Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA.

Kristina Sundquist (K)

Center for Primary Health Care Research, Lund University, Malmö, Sweden.

Jan Sundquist (J)

Center for Primary Health Care Research, Lund University, Malmö, Sweden.

Kenneth S Kendler (KS)

Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA.
Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

Sara Larsson Lönn (S)

Center for Primary Health Care Research, Lund University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH